Annual Total Long Term Liabilities
$62.95 M
+$1.18 M+1.91%
December 31, 2023
Summary
- As of February 24, 2025, ACAD annual total long term liabilities is $62.95 million, with the most recent change of +$1.18 million (+1.91%) on December 31, 2023.
- During the last 3 years, ACAD annual total long term liabilities has risen by +$13.31 million (+26.81%).
- ACAD annual total long term liabilities is now -17.33% below its all-time high of $76.14 million, reached on December 31, 2003.
Performance
ACAD Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$55.74 M
-$3.81 M-6.39%
September 30, 2024
Summary
- As of February 24, 2025, ACAD quarterly total long term liabilities is $55.74 million, with the most recent change of -$3.81 million (-6.39%) on September 30, 2024.
- Over the past year, ACAD quarterly long term liabilities has stayed the same.
- ACAD quarterly long term liabilities is now -26.79% below its all-time high of $76.14 million, reached on December 31, 2003.
Performance
ACAD Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ACAD Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.9% | 0.0% |
| 3 y3 years | +26.8% | -10.8% |
| 5 y5 years | +3940.2% | +551.7% |
ACAD Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.3% | +1.9% | -11.7% | at low |
| 5 y | 5-year | -0.3% | +582.6% | -13.3% | +504.5% |
| alltime | all time | -17.3% | >+9999.0% | -26.8% | -100.0% |
ACADIA Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $55.74 M(-6.4%) |
| Jun 2024 | - | $59.55 M(-1.5%) |
| Mar 2024 | - | $60.46 M(-3.9%) |
| Dec 2023 | $62.95 M(+1.9%) | $62.95 M(+3.6%) |
| Sep 2023 | - | $60.76 M(+2.9%) |
| Jun 2023 | - | $59.03 M(+4.0%) |
| Mar 2023 | - | $56.75 M(-8.1%) |
| Dec 2022 | $61.77 M(-2.2%) | $61.77 M(+2.5%) |
| Sep 2022 | - | $60.23 M(-0.0%) |
| Jun 2022 | - | $60.24 M(+0.6%) |
| Mar 2022 | - | $59.85 M(-5.2%) |
| Dec 2021 | $63.16 M(+27.2%) | $63.16 M(+1.1%) |
| Sep 2021 | - | $62.50 M(-2.7%) |
| Jun 2021 | - | $64.26 M(+0.1%) |
| Mar 2021 | - | $64.19 M(+29.3%) |
| Dec 2020 | $49.64 M(+438.3%) | $49.64 M(+1.4%) |
| Sep 2020 | - | $48.94 M(+379.2%) |
| Jun 2020 | - | $10.21 M(+9.5%) |
| Mar 2020 | - | $9.33 M(+1.1%) |
| Dec 2019 | $9.22 M(+491.9%) | $9.22 M(+7.8%) |
| Sep 2019 | - | $8.55 M(+4.9%) |
| Jun 2019 | - | $8.15 M(+5.0%) |
| Mar 2019 | - | $7.77 M(+398.5%) |
| Dec 2018 | $1.56 M(+715.7%) | $1.56 M(+28.9%) |
| Sep 2018 | - | $1.21 M(+17.8%) |
| Jun 2018 | - | $1.03 M(+31.2%) |
| Mar 2018 | - | $782.00 K(+309.4%) |
| Dec 2017 | $191.00 K(+21.7%) | $191.00 K(-22.0%) |
| Sep 2017 | - | $245.00 K(-6.5%) |
| Jun 2017 | - | $262.00 K(+17.0%) |
| Mar 2017 | - | $224.00 K(+42.7%) |
| Dec 2016 | $157.00 K(-32.3%) | $157.00 K(-11.3%) |
| Sep 2016 | - | $177.00 K(-10.2%) |
| Jun 2016 | - | $197.00 K(-9.2%) |
| Mar 2016 | - | $217.00 K(-6.5%) |
| Dec 2015 | $232.00 K(+71.9%) | $232.00 K(-2.9%) |
| Sep 2015 | - | $239.00 K(-29.7%) |
| Jun 2015 | - | $340.00 K(+56.0%) |
| Mar 2015 | - | $218.00 K(+61.5%) |
| Dec 2014 | $135.00 K(+1587.5%) | $135.00 K(+542.9%) |
| Sep 2014 | - | $21.00 K(+16.7%) |
| Jun 2014 | - | $18.00 K(+38.5%) |
| Mar 2014 | - | $13.00 K(+62.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $8000.00(-100.0%) | $8000.00(-99.9%) |
| Sep 2013 | - | $10.66 M(-39.6%) |
| Jun 2013 | - | $17.66 M(0.0%) |
| Mar 2013 | - | $17.66 M(0.0%) |
| Dec 2012 | $17.66 M(+582.6%) | $17.66 M(>+9900.0%) |
| Sep 2012 | - | $0.00(-100.0%) |
| Jun 2012 | - | $2.41 M(-3.8%) |
| Mar 2012 | - | $2.50 M(-3.3%) |
| Dec 2011 | $2.59 M(-5.8%) | $2.59 M(+4.8%) |
| Sep 2011 | - | $2.47 M(-2.8%) |
| Jun 2011 | - | $2.54 M(-3.8%) |
| Mar 2011 | - | $2.64 M(-3.9%) |
| Dec 2010 | $2.75 M(-88.0%) | $2.75 M(-87.9%) |
| Sep 2010 | - | $22.76 M(-1.2%) |
| Jun 2010 | - | $23.03 M(+1.8%) |
| Mar 2010 | - | $22.63 M(-1.0%) |
| Dec 2009 | $22.86 M(+3505.5%) | $22.86 M(-5.8%) |
| Sep 2009 | - | $24.26 M(+6.8%) |
| Jun 2009 | - | $22.71 M(+4037.3%) |
| Mar 2009 | - | $549.00 K(-13.4%) |
| Dec 2008 | $634.00 K(-53.5%) | $634.00 K(-16.5%) |
| Sep 2008 | - | $759.00 K(-23.1%) |
| Jun 2008 | - | $987.00 K(-16.8%) |
| Mar 2008 | - | $1.19 M(-13.0%) |
| Dec 2007 | $1.36 M(-26.4%) | $1.36 M(-6.5%) |
| Sep 2007 | - | $1.46 M(-10.3%) |
| Jun 2007 | - | $1.63 M(-3.3%) |
| Mar 2007 | - | $1.68 M(-9.2%) |
| Dec 2006 | $1.85 M(+29.1%) | $1.85 M(+6.0%) |
| Sep 2006 | - | $1.75 M(+1.7%) |
| Jun 2006 | - | $1.72 M(-10.4%) |
| Mar 2006 | - | $1.92 M(+33.6%) |
| Dec 2005 | $1.43 M(+37.4%) | $1.43 M(+3.6%) |
| Sep 2005 | - | $1.38 M(-1.3%) |
| Jun 2005 | - | $1.40 M(-24.6%) |
| Mar 2005 | - | $1.86 M(+78.3%) |
| Dec 2004 | $1.04 M(-98.6%) | $1.04 M(+1.7%) |
| Sep 2004 | - | $1.03 M(+8.5%) |
| Jun 2004 | - | $946.30 K(-98.7%) |
| Mar 2004 | - | $75.39 M(-1.0%) |
| Dec 2003 | $76.14 M(+52.4%) | $76.14 M |
| Dec 2002 | $49.96 M(+3676.3%) | - |
| Dec 2001 | $1.32 M(-77.1%) | - |
| Dec 2000 | $5.79 M | - |
FAQ
- What is ACADIA Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual total long term liabilities year-on-year change?
- What is ACADIA Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly long term liabilities year-on-year change?
What is ACADIA Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ACAD is $62.95 M
What is the all time high annual total long term liabilities for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual total long term liabilities is $76.14 M
What is ACADIA Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ACAD annual total long term liabilities has changed by +$1.18 M (+1.91%)
What is ACADIA Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ACAD is $55.74 M
What is the all time high quarterly long term liabilities for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly total long term liabilities is $76.14 M
What is ACADIA Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ACAD quarterly total long term liabilities has changed by $0.00 (0.00%)